David H. RAULET
University of California, Berkeley
H-index: 108
North America-United States
Top articles of David H. RAULET
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
The activation of the adaptor protein STING depends on its interactions with the phospholipid PI4P | Science signaling | Rutger D Luteijn Sypke R van Terwisga Jill E Ver Eecke Liberty Onia Shivam A Zaver | 2024/3/12 |
Roles of natural killer cells in immunity to cancer, and applications to immunotherapy | Natalie K Wolf Djem U Kissiov David H Raulet | 2023/2 | |
Induced CD45 Proximity Potentiates Natural Killer Cell Receptor Antagonism | ACS synthetic biology | Junming Ren Yeara Jo Lora K Picton Leon L Su David H Raulet | 2022/9/28 |
Synergy of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I–deficient and MHC I+ tumors | Proceedings of the National Academy of Sciences | Natalie K Wolf Cristina Blaj Lora K Picton Gail Snyder Li Zhang | 2022/5/31 |
Binary outcomes of enhancer activity underlie stable random monoallelic expression | Elife | Djem U Kissiov Alexander Ethell Sean Chen Natalie K Wolf Chenyu Zhang | 2022/5/26 |
INAUGURAL ARTICLE by a Recently Elected Academy Member: Synergy of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I–deficient and MHC I+ tumors | Proceedings of the National Academy of Sciences of the United States of America | Tori M Hoehler Dylan J Mankel Peter R Girguis Thomas M McCollom Nancy Y Kiang | 2023/6/6 |
STING activation depends on ACBD3 and other phosphatidylinositol 4-phosphate-regulating proteins | bioRxiv | Rutger D Luteijn Sypke R van Terwisga Jill E Ver Eecke Liberty Onia Shivam A Zaver | 2022/10/17 |
584 Powerful synergistic effects of a STING agonist and the IL-2 superkine, H9, in eliciting NK and T cell responses against MHC I-and MHC I+ tumors | Natalie Wolf Cristina Blaj Lora Picton Gail Snyder Li Zhang | 2021/11/1 | |
Tumor-induced disruption of the blood-brain barrier promotes host death | Developmental cell | Jung Kim Hsiu-Chun Chuang Natalie K Wolf Christopher J Nicolai David H Raulet | 2021/10/11 |
Methods of Modulating Activity of a Cyclic Dinucleotide (CDN) with a CDN Transporter-Modulating Agent | 2021/9/9 | ||
Innate immune cells in the tumor microenvironment | Cancer Cell | Ming O Li Natalie Wolf David H Raulet Leila Akkari Mikael J Pittet | 2021/6/14 |
Abstract IA05: Innate immune defenses against cancer: Potential for mobilizing NK cells for cancer immunotherapy | Cancer Immunology Research | David H Raulet | 2021/2/1 |
Powerful synergistic effects of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I-deficient and MHC I+ tumors | bioRxiv | Natalie Wolf Cristina Blaj Lora Picton Gail Snyder Li Zhang | 2021/11/2 |
Millikelvin-resolved ambient thermography | Science advances | Kechao Tang Kaichen Dong Christopher J Nicolai Ying Li Jiachen Li | 2020/12/9 |
Killer cells add fire to fuel immunotherapy | Science | Christopher J Nicolai David H Raulet | 2020/5/29 |
Combination therapy to enhance NK cell anti-tumor responses | The Journal of Immunology | Natalie K Wolf Chris Nicolai Susanna Dang Gail Synder Cristina Blaj | 2020/5/1 |
NK cells mediate clearance of CD8+ T cell–resistant tumors in response to STING agonists | Science immunology | Christopher J Nicolai Natalie Wolf I-Chang Chang Georgia Kirn Assaf Marcus | 2020/3/20 |
Author Correction: SLC19A1 transports immunoreactive cyclic dinucleotides | Nature | Rutger D Luteijn Shivam A Zaver Benjamin G Gowen Stacia K Wyman Nick E Garelis | 2020/3 |
